Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PE Biosystems, Third Wave terminate merger

The companies mutually terminated their previously announced merger, under which PEB was to acquire nucleic acid

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE